Strategies to Mitigate Weight Regain After Semaglutide-Based Injectables

Simple strategies can help individuals maintain weight loss achieved through medications like Mounjaro and Wegovy, potentially slashing weight regain by two-thirds, according to recent findings. Experts suggest that a structured approach when ending these injectable treatments is crucial to prevent the return of lost pounds.

For millions who have lost weight on Mounjaro or Wegovy, a significant concern is whether the weight will return once they stop the medication. Evidence suggests that gradually reducing the dose, rather than stopping abruptly, can be more effective in sustaining weight loss.

Experts propose a set of eight rules to follow when discontinuing these weight-loss injections. These guidelines focus on supporting the body's transition and reinforcing healthy habits. The research indicates that having the right support systems in place post-treatment can make a substantial difference in long-term weight management.

One recommended strategy involves a gradual tapering of the medication dose. This approach allows the body to adjust more slowly to the absence of the drug's appetite-suppressing effects, thereby helping to mitigate the risk of rapid weight regain. This contrasts with an abrupt cessation, which may lead to a quicker return of appetite and subsequent weight accumulation.

Beyond medication management, lifestyle factors play a pivotal role. Experts emphasize the importance of continued adherence to a healthy diet and regular physical activity. Establishing and maintaining these habits before and during the tapering process can provide a strong foundation for long-term success. The aim is to transition from relying on medication to sustaining weight loss through sustainable behavioral changes.